Journal article
Early and delayed tranilast treatment reduces pathological fibrosis following myocardial infarction
F See, M Watanabe, AR Kompa, BH Wang, AJ Boyle, DJ Kelly, RE Gilbert, H Krum
Heart Lung and Circulation | Published : 2013
Abstract
Background: Tranilast has been shown to inhibit TGFβ1-related fibrosis and organ failure in various disease models. We sought to examine the effects of tranilast on left ventricular (LV) remodelling post-MI. Methods: Following coronary artery ligation, Sprague Dawley rats were randomised to receive tranilast (300. mg/kg/d, p.o.) or vehicle control over one of two treatment periods: (1) from 24. h until seven days post-MI, (2) from seven days to 28 days post-MI. Cardiac tissue was harvested for molecular, immunohistochemical and cell culture analyses. Results: Tranilast treatment of MI rats from 24. h until seven days post-MI reduced myocardial collagen content, α1 (I) procollagen, TGFβ1 and ..
View full abstractGrants
Awarded by Canadian Diabetes Association
Funding Acknowledgements
Dr. Kelly is an NHMRC Senior Fellow. Dr. Gilbert is a Canada Research Chair in Diabetes Complications and this work was supported thanks, in part, to the Canadian Diabetes Association and the Canada Research Chair Programme. This work was supported by a NHMRC programme grant ID (334008).